ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Silvr, I agree that money aside, it has been long overdue.

Something to consider, in treating HSDD the current guidance would have every other avenue exhausted before trying Testosterone and even then it will be for a short period of time to see if it works. In some cases they will stop for lack of benefit. Additionally not all, women who have low testosterone, will suffer from HSDD.

When it comes to reducing risk of cardiovascular event and breast cancer event it will be a very much different story. If the are at risk and have low testosterone, they are more apt to prescribe it and patients will continue using it. Arguably a larger and more sustainable market.

Currently if they get the approvals for patents regarding CV and Breast Cancer event reduction it is possible both parents could extend to 2036 and possibly beyond.